Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the genital herpes market right now?

In recent times, the market size for genital herpes has seen a significant growth. The market is projected to increase from $2.19 billion in 2024 to $2.34 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Factors attributing to the growth during the historical period include increased awareness and diagnosis, progressive advancements in treatment, better accessibility to healthcare, public health promotions, and various socio-demographic elements.

How fast Is the genital herpes market expected to grow, and what’s its future value?

The size of the genital herpes market is projected to display robust growth over the coming years, expanding to $3.05 billion by 2029 with a compound annual growth rate (CAGR) of 6.8%. The anticipated growth during the forecast years can be linked to increased education and awareness, progress in treatments and vaccines, augmented incidence rates, advancements in digital health technologies, wider healthcare access, and escalated sexually transmitted infection awareness programs. The period is set to witness major trends such as the adoption of telemedicine, progress in antiviral therapies, expansion of healthcare accessibility, breakthroughs in vaccine research and development, heightened public awareness initiatives, and the incorporation of AI and data examination in the sector.

Get your genital herpes market report here!

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

What are the leading drivers of growth in the genital herpes market?

An increased emphasis on sexual health is anticipated to fuel the expansion of the genital herpes market in the future. The growing attention to sexual health arises from an enhanced understanding of its crucial contribution to overall well-being and life quality. Services for sexual health related to genital herpes mainly encompass diagnosis, treatment, counseling and ongoing management, designed to aid individuals in handling outbreaks, preventing transmission, and dealing with the emotional and relationship issues arising from the disease. For example, as per the Local Government Association, a national membership body in the UK, the demand for sexual health services saw a surge in January 2024, with close to 4.5 million consultations taking place in 2022, a jump of 33%. In addition, there was notable activity in diagnostic testing, with 2.2 million tests being conducted in 2022, a 13% increase from 2021. Consequently, the amplified focus on sexual health is forecast to stimulate the growth of the genital herpes market.

What are the key segments defining the genital herpes market?

The genital herpes market covered in this report is segmented –

1) By Type: Diagnosis, Treatment

2) By Route Of Administration: Oral, Injectable, Topical

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channel

Subsegments:

1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests, Viral Culture Tests, Blood Antibody Tests (Serology), Antigen Detection Tests, Point-Of-Care Rapid Tests

2) By Treatment: Antiviral Medications, Acyclovir, Valacyclovir, Famciclovir, Topical Treatments, Acyclovir Cream, Docosanol Cream, Preventive Therapies, Suppressive Therapy, Prophylactic Vaccines (Under Development), Pain Management Medications, Analgesics, Topical Anesthetics

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17161&type=smp

Who are the key players steering the development of the genital herpes market?

Major companies operating in the genital herpes market are Pfizer Inc, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, BioNTech SE, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi AG, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Bausch + Lomb Corporation, Dr. Reddy’s Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Romark Laboratories, Eurocine Vaccines AB, Vical Incorporated

What are the key trends shaping the future of the genital herpes market?

Established entities in the genital herpes sector are utilizing strategic partnerships as a tactic to broaden their technological proficiency and market penetration. A strategic partnership often alludes to a joint venture between a minimum of two organizations wherein they merge their resources, specialties, and endeavors to realize mutual aims or objectives. For example, Eurocine Vaccines AB, a Biotech firm based in Sweden known for its work in herpes disease treatments, declared a research and collaboration agreement with Redbiotec AG, a biotech firm in Switzerland, in June 2022. This agreement granted them sole global rights for the development, production, and distribution of vaccine candidates aimed at Herpes Simplex Virus Type 2 (HSV-2). This covers both the mRNA- and protein-based technologies, including linked documentation and patents in the HSV-2 domain. Eurocine Vaccines is in charge of all development, production, and distribution associated activities until an out-licensing agreement is solidified with another party.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17161

Which regions are most influential in expanding the genital herpes market?

North America was the largest region in the genital herpes market in 2023. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cryogenic Pump Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-pump-global-market-report

Congenital Diaphragmatic Hernia Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/congenital-diaphragmatic-hernia-drugs-global-market-report

Cryogenic Insulation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: